Pneumonectomy Raises Lung Resection Mortality Risk: Presented at STS
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Pneumonectomy Raises Lung Resection Mortality Risk: Presented at STS

By Charlene Laino

FORT LAUDERDALE, Fla -- January 27, 2010 -- The strongest predictors of mortality after resection for lung cancer are pneumonectomy and poor performance status, according to a retrospective review presented here at the Society of Thoracic Surgeons (STS) 46th Annual Meeting.

“We found some very powerful predictors of mortality that will help improve patient care in the future,” said Benjamin D. Kozower, MD, Surgery and Public Health Sciences, University of Virginia, Charlottesville, Virginia, on January 25.

The researchers reviewed data in the STS General Thoracic Database on 18,800 patients who had undergone surgery for lung cancer between 2002 and 2008.

“Two-thirds of patients had a lobectomy for their lung resection,” said Dr. Kozower. “Wedge resection was the second most common procedure, and pneumonectomies were rare, at 6%.”

Perioperative mortality occurred in 413 patients (2.2%). Major morbidity occurred in 1,491 patients (7.9%). The median length of stay following lung cancer resection was 5 days.

The greatest predictor of mortality was pneumonectomy, which increased the risk of dying 3.9-fold, compared with lobectomy (P < .001).

Poor physical status before surgery increased the mortality risk 3.6-fold (P = .004) and poor performance status increased the risk 3.1-fold (P < .001).

Induction chemoradiation therapy, but not induction chemotherapy alone, doubled the risk of death (P = .01). Steroids were also an important predictor of mortality, raising risk 1.9 fold (P = .002).

[Presentation title: Predictors of Mortality and Major Morbidity After Resection for Lung Cancer -- A Society of Thoracic Surgeons General Thoracic Surgery Database
Risk Model. Abstract 2]


E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities